phage

(redirected from Phages)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Phages: Bacteriophage therapy

phage

 (fāj)
n.
A bacteriophage.

phage

(feɪdʒ)
n
(Microbiology) short for bacteriophage

phage

(feɪdʒ)

n.
[by shortening]

-phage

a combining form meaning “a thing that devours,” used esp. in the names of viruses and phagocytes: bacteriophage; macrophage.
[n. use of Greek -phagos -phagous]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.phage - a virus that is parasitic (reproduces itself) in bacteria; "phage uses the bacterium's machinery and energy to produce more phage until the bacterium is destroyed and phage is released to invade surrounding bacteria"
virus - (virology) ultramicroscopic infectious agent that replicates itself only within cells of living hosts; many are pathogenic; a piece of nucleic acid (DNA or RNA) wrapped in a thin coat of protein
coliphage - a bacteriophage that infects the bacterium Escherichia coli
typhoid bacteriophage - a bacteriophage specific for the bacterium Salmonella typhi
Translations

phage

[ˈfeɪdʒ] n (=bacteriophage) → phage m

phage

n. bacteriófago.
References in periodicals archive ?
Scientists have successfully used an experimental therapy that relies on bacteria-infecting viruses (bacteriophages or phages) collected, in part, through a Howard Hughes Medical Institute (HHMI) program to fight a Mycobacterium infection in a 15-year-old girl.
Armata's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to Armata's ability to successfully integrate the operations of AmpliPhi and C3J and achieve the potential benefits of the merger; the Company's ability to advance its preclinical and clinical programs and the uncertain and time-consuming regulatory approval process; the Company's ability to develop products based on bacteriophages and synthetic phages to kill bacterial pathogens; the Company's expected market opportunity for its products and the Company's ability to sufficiently fund its operations as expected.
Phage product launch in pipeline such as AP-SA01 (cocktail of three natural (unmodified) lytic phages developed for the treatment of S.
As the threat of antibiotic resistance increases, bacteriophages, or phages for short, may prove useful in fighting bacteria that cannot be killed by antibiotics alone.
Bacteriophages, or "phages," are a category of highly adept and adaptable viruses that can infect and kill bacteria.
There are also issues of phage variation with "rescuing" phages as the rescued phage may mutate or otherwise differ from the original, preserved phage (Cuevas et al., 2009; Drake, 1991; Santos and Drake, 1994; Wichman et al., 2005).
The stx genes are encoded by lambdalike phages and have been acquired by STEC strains through phage transduction (3).
Bacteriophages, or more simply "phages," are the natural predators of bacteria and are thought to be the most abundant life form on earth.
Based in the Netherlands, the company's new PhageGuard-E product consists of natural phages against E.coli and the product is produced in Europe.
A study led by a researcher at the University of Colorado Anschutz Medical Campus focused on viruses inhabiting bacteria in the intestine known as bacteriophages or simply phages.